Physico-chemical Analysis |
No. |
Parameter |
Duration Analysis |
Method |
1 |
Antibiotics microbial assays |
5 days |
USP 47 NF 42 |
2 |
Appearances |
1 day |
EP 11.0 |
3 |
Assay (HPLC) |
2 days |
HPLC |
4 |
Assay (Spectrophotometry UV) |
1 day |
UV spectrum |
5 |
Average mass/volume |
1 day |
USP 47 NF 42 |
6 |
Disintegration (Tablet, capsule, suppository and ovule) |
1 day |
USP 47 NF 42 |
7 |
Identification (IR Spectrum) |
1 day |
Compare CRS (EDQM/ USP) |
8 |
Identification (TLC) |
2 days |
USP 47 NF 42 |
9 |
Loss on drying (moisture) |
1 day |
EP 11.0 |
10 |
pH |
1 day |
EP 11.0 |
11 |
Related substance/ Total impurity |
3 days |
HPLC |
12 |
Water content (Karl Fischer) |
1 day |
Automatic titration |
Microbiological Analysis |
No. |
Parameter |
Duration Analysis |
Method |
1 |
Bile-tolerant gram-negative bacteria |
5 days |
USP 47 NF 42 |
2 |
Candida albicans |
5 days |
USP 47 NF 42 |
3 |
Efficacy of antimicrobial preservation |
5 days |
USP 47 NF 42 |
4 |
Escherichia.coli |
5 days |
USP 47 NF 42 |
5 |
Gram-negative bacteria |
5 days |
USP 47 NF 42 |
6 |
Pseudomonas aeruginosa |
5 days |
USP 47 NF 42 |
7 |
Saccharomyces |
5 days |
USP 47 NF 42 |
8 |
Salmonella |
5 days |
USP 47 NF 42 |
9 |
Staphylococcus aureus |
5 days |
USP 47 NF 42 |
10 |
Total aerobic microbial count |
5 days |
USP 47 NF 42 |
11 |
Total combined yeasts/molds count |
7 days |
USP 47 NF 42 |
12 |
Personal hygiene test (TAMC&TYMC) |
7 days |
USP 47 NF 42 |
13 |
Room cleanliness control (air contamination control) (TAMC&TYMC) |
7 days |
USP 47 NF 42 |
14 |
Surface swabs from establishment (Equipment and facilities) (TAMC&TYMC) |
7 days |
USP 47 NF 42 |
Stability Study (Shelf life study) |
No. |
Parameter |
Duration Analysis |
Method |
1 |
Real time study ( T0, T3,T6, T9,T12, T18,T24 & T36) |
Base on selected parameters |
ASEAN Guidline version2 |
2 |
Acelerate study (T0, T3,T6, T9 & T12) |
Base on selected parameters |
ASEAN Guidline version2 |
Packages fee |
No. |
Product |
Recommended Test Parameters |
1 |
Aerosols (pressurised pharmaceutical preparations) |
Identification of the Active substance |
2 |
Aerosols (pressurised pharmaceutical preparations) |
Active substance assay |
3 |
Aerosols (pressurised pharmaceutical preparations) |
Preservative content (where appropriate) |
4 |
Capsules |
Appearance |
5 |
Capsules |
Identification of the active substance |
6 |
Capsules |
Uniformity of content/mass |
7 |
Capsules |
Active substance assay |
8 |
Capsules |
Impurities (where appropriate) |
9 |
Capsules |
Disintegration time |
10 |
Capsules |
Dissolution profile (where appropriate) |
11 |
Collars/ear tags |
Appearance |
12 |
Collars/ear tags |
Identification of the active substance |
13 |
Collars/ear tags |
Uniformity of content/mass |
14 |
Collars/ear tags |
Active substance assay |
15 |
Oral powders, Granules |
Appearance, colour, clarity |
16 |
Oral powders, Granules |
Identification of the active substance |
17 |
Oral powders, Granules |
Active substance assay |
18 |
Oral powders, Granules |
Moisture content |